At1 receptor blockers improve endothelial function (EF) and fibrinolytic activity (FA) in hypertensive patients with initial target organ damage
Author(s) -
M CAMPANELLA
Publication year - 2004
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2004.03.161
Subject(s) - medicine , microalbuminuria , valsartan , endocrinology , plasminogen activator , endothelial dysfunction , tissue plasminogen activator , diabetes mellitus , heart failure , von willebrand factor , cardiology , plasminogen activator inhibitor 1 , fibrinolysis , angiotensin ii receptor type 1 , gastroenterology , blood pressure , angiotensin ii , platelet
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom